Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07769021
Starting soon Observational

Tracheostomy Practice in Adult Intensive Care Units

NCT07769021 · tracked via the Priya Life Science Brazil tracker
Sponsor
Royal College of Surgeons, Ireland
Phase
Observational
Started
2026-11-02
Last updated
2026-08-17

Condition(s) studied

Tracheostomy PatientsTracheostomy DecannulationIntensive Care (ICU)

Study summary

ON TRACH is an international, multicentre, observational study with the aim of characterising the timing and practice of tracheostomy insertion, management, weaning and longer-term outcomes of these patients, in intensive care units internationally. Participating intensive care units (ICU) will recruit all consecutive patients undergoing tracheostomy insertion over a 12 week period, aiming for broad global representation. This will allow identification of variation in care of patients with a tracheostomy in the intensive care and it's origin, to drive improvement and enhance safety and outcomes for patients with a tracheostomy in the future.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Greater than 18 years of age * Tracheostomy insertion during critical care admission Exclusion Criteria: * Tracheostomy prior to critical care admission * Elective tracheostomy insertion for head and neck pathology * Tracheostomy insertion for emergency surgical management of airway obstruction * Mini tracheostomy insertion only

Primary outcome measure(s)

Trial sites (13)

FacilityCityRegionStatus
Beth Israel Medical Centre Boston Massachusetts
University of Michigan Health Ann Arbor Ann Arbor Michigan
Nereu Ramos Hospital Florianópolis Brazil
Toronto General Hospital Toronto Canada
Tata Memorial Hospital Mumbai India
Beaumont Hospital Dublin Ireland
Mater Misericordiae University Hospital Dublin Dublin Ireland
Galway University Hospital Galway Ireland
Ospedale Policlinico San Martino Genoa Genova Italy
University of Naples Frederico II Naples Italy
University Hospital San Luigi Gonzaga Turin Torino Italy
University Hospital of Lausanne Lausanne Switzerland
Manchester University Hospital Manchester United Kingdom
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07769021 on ClinicalTrials.gov ↗ ← All trials in Brazil